Treatment of Sleep-Related Hypoventilation
The primary treatment for sleep-related hypoventilation is positive airway pressure (PAP) therapy, with the specific type of PAP determined by the underlying cause and severity of hypoventilation.
Diagnosis and Assessment
- Sleep-related hypoventilation is characterized by abnormal gas exchange during sleep that leads to elevated CO2 levels 1
- Polysomnography with continuous CO2 monitoring is the gold standard for diagnosis and assessment of sleep-related hypoventilation 2
- In areas where polysomnography is not readily available, overnight pulse oximetry with continuous CO2 monitoring can be used to monitor nighttime gas exchange 2
- Simple oximetry alone provides only indirect information on ventilation and should be used only when better alternatives are unavailable 2
- Serum bicarbonate >27 mmol/L can be used as a screening tool to identify patients who may need arterial blood gas analysis to diagnose hypoventilation 2
Treatment Algorithm
For Obesity Hypoventilation Syndrome (OHS):
For stable ambulatory patients with OHS and severe OSA (AHI >30 events/h):
For OHS patients with sleep hypoventilation without severe OSA:
- Noninvasive ventilation (NIV) is recommended 2
For hospitalized patients with respiratory failure suspected of having OHS:
Weight loss interventions:
For Neuromuscular Disorders (e.g., Duchenne Muscular Dystrophy):
For sleep-related hypoventilation:
- Use nasal intermittent positive pressure ventilation (NIPPV) to treat sleep-related upper airway obstruction and chronic respiratory insufficiency 2
- Do not use oxygen alone to treat sleep-related hypoventilation without ventilatory assistance 2
- Negative-pressure ventilators should be used with caution due to the risk of precipitating upper airway obstruction and hypoxemia 2
For progression to daytime hypoventilation:
- Consider daytime ventilation when measured waking PCO2 exceeds 50 mm Hg or when hemoglobin saturation remains ≤92% while awake 2
- Options include mouthpiece intermittent positive pressure ventilation, glossopharyngeal breathing, intermittent abdominal pressure ventilation, or negative-pressure ventilation 2
PAP Titration Guidelines
- The NPPV device used for titration should have capability of operating in spontaneous, spontaneous timed, and timed modes 2
- Minimum starting IPAP and EPAP should be 8 cm H2O and 4 cm H2O, respectively 2
- Maximum IPAP should be 30 cm H2O for patients ≥12 years and 20 cm H2O for patients <12 years 2
- Minimum and maximum levels of pressure support are 4 cm H2O and 20 cm H2O, respectively 2
- Increase pressure support if tidal volume is low (<6-8 mL/kg) or if arterial PCO2 remains 10 mm Hg or more above the PCO2 goal for 10 minutes or more 2
- A backup rate (ST mode) should be used in patients with central hypoventilation, those with significant central apneas, or those who unreliably trigger IPAP/EPAP cycles due to muscle weakness 2
Monitoring and Follow-up
- Schedule periodic reassessment appropriate to the stage of disease 2
- Follow-up visits should include monitoring for the development of daytime hypoventilation, which may necessitate around-the-clock ventilation 2
- Regular monitoring of gas exchange with or without full polysomnography is necessary to comprehensively assess this disorder, especially in early stages 3
Clinical Considerations and Pitfalls
- Do not use supplemental oxygen alone to treat sleep-related hypoventilation, as this may worsen hypercapnia without addressing the underlying ventilatory problem 2
- Sleep-related hypoventilation may occur even with normal daytime PCO2 levels, so nighttime monitoring is essential for diagnosis 4
- Mask displacement can rapidly lead to severe hypoxemia and hypercapnia in fragile patients; additional monitoring such as pulse oximetry is useful 2
- When appropriately selected patients use therapy regularly, significant improvements in quality of life, exercise capacity, and survival can be achieved, regardless of the underlying disease process 3